Retension Pharmaceuticals, Inc.
Retension Pharmaceuticals, Inc. scores highest on Nitro (93) and lowest on Price (0). Its PosiPenta is 52.19 out of 100, around the middle of similar companies.
On the Penta Grid this week, Retension Pharmaceuticals, Inc. is Grid #250 of 837 in the Healthcare sector in United States, and Grid #1,625 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Retension Pharmaceuticals, Inc. | 52.19 | 0 | 27 | 93 | 88 | 54 |
| Armata Pharmaceuticals, Inc. | 42.59 | 0 | 38 | 24 | 96 | 54 |
| TuHURA Biosciences, Inc. | 38.49 | 11 | 40 | 59 | 25 | 58 |
| Health Catalyst, Inc. | 39.73 | 36 | 50 | 51 | 18 | 44 |
| Cumberland Pharmaceuticals Inc. | 57.38 | 11 | 72 | 83 | 53 | 68 |
| Spruce Biosciences, Inc. | 33.89 | 35 | 43 | 21 | 40 | 31 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -5.39 |
| P/B ratio | -0.76 |
EEarnings
| Trailing EPS | ₹-247.21 |
| Forward EPS | — |
NNitro
| Price | 1332.64 |
| 52-week high | 1418.06 |
| 52-week low | 914.95 |
| Fall from 52-week high | 6.0% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹1,110 Cr |
| Insider holding | 17.61% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Retension Pharmaceuticals, Inc.'s PosiPenta score?
Retension Pharmaceuticals, Inc.'s PosiPenta is 52.19 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Retension Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Retension Pharmaceuticals, Inc. is Grid #250 of 837 in the Healthcare sector in United States, and Grid #1,625 of 4,000 in United States.
Which PosiPenta pillar is strongest for Retension Pharmaceuticals, Inc.?
Nitro (momentum), with a score of 93 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Retension Pharmaceuticals, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.